Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Spectrum selects Fusilev as tradename for levoleucovorin for injection

June 18, 2008

Adventrx reports CoFactor phase IIb overall survival results

June 18, 2008

Oncothyreon initiates phase I PX-866 trial in patients with solid tumors

June 18, 2008

JX-594 well tolerated, active in refractory primary and metastatic liver cancer

June 18, 2008

Exelixis and FDA agree on Special Protocol Assessment for XL-184 phase III trial

June 18, 2008

New phase I and II data on BIBW-2992 reported

June 18, 2008

CBP-501 well tolerated alone and with cisplatin in phase I solid tumor studies

June 18, 2008

LLS and Aegera to initiate phase I/II trial of targeted blood cancer therapy AEG-35156

June 17, 2008

Phase I studies characterize MK-0646 in solid tumor patients

June 17, 2008

Z-360 safe when combined with gemcitabine in pancreatic cancer patients

June 17, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...